PAPILLARY THYROID CANCER
Clinical trials for PAPILLARY THYROID CANCER explained in plain language.
Never miss a new study
Get alerted when new PAPILLARY THYROID CANCER trials appear
Sign up with your email to follow new studies for PAPILLARY THYROID CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill targets cancer's genetic weak spot in 15 tumor types
Disease control OngoingThis study tests an experimental drug called entrectinib in people with advanced solid tumors that have certain gene changes (NTRK, ROS1, or ALK). The drug aims to shrink or control the cancer by blocking signals that help it grow. About 534 adults with various cancers, including…
Matched conditions: PAPILLARY THYROID CANCER
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 26, 2026 10:34 UTC
-
New pill shows promise against rare childhood cancers
Disease control OngoingThis study tests an oral drug called LOXO 292 in 36 children with advanced solid or brain tumors that have a specific genetic change (RET alteration). The goal is to see if the drug can shrink tumors and control the disease. Participants must have already tried standard treatment…
Matched conditions: PAPILLARY THYROID CANCER
Phase: PHASE1, PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 19, 2026 11:49 UTC
-
New drug combo shows promise for Hard-to-Treat thyroid cancer
Disease control OngoingThis study tests whether a drug called PDR001, combined with either trametinib or dabrafenib, is safe and effective for people with thyroid cancer that no longer responds to standard radioactive iodine treatment. The trial enrolled 19 adults whose cancer had worsened. The main go…
Matched conditions: PAPILLARY THYROID CANCER
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 08, 2026 12:01 UTC
-
New study: monitoring small thyroid cancers may be as effective as surgery
Knowledge-focused OngoingThis study looks at two ways to manage very low-risk papillary thyroid cancer: active surveillance (regular check-ups to watch for changes) or immediate surgery. Researchers want to see how often each approach fails to control the disease over the long term. About 450 adults with…
Matched conditions: PAPILLARY THYROID CANCER
Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated May 20, 2026 11:54 UTC
-
Pee power: urine test could replace needles for thyroid cancer Follow-Up
Knowledge-focused OngoingThis study explores whether substances found in urine can help doctors track thyroid cancer after treatment. Researchers are measuring specific proteins in the urine of 103 patients who had their thyroid removed. The goal is to find a simple, non-invasive way to monitor the disea…
Matched conditions: PAPILLARY THYROID CANCER
Sponsor: National Taiwan University Hospital • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC